Article info

Original research
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis

Authors

  1. Correspondence to Professor Pamela J Shaw, Sheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield, Sheffield, UK; pamela.shaw{at}sheffield.ac.uk
View Full Text

Citation

Shepheard SR, Parker MD, Cooper-Knock J on behalf of the Project MINE Consortium, et al
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis

Publication history

  • Received September 1, 2020
  • Revised November 15, 2020
  • Accepted November 25, 2020
  • First published February 14, 2021.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.